TSE:MFC

Manulife Financial (MFC.TO)

53.50
+0.47 (0.89%)
as of Jun 4, 2026, 8:00:00 pm Market Open.
1636 watching
0
Investor Insights
star iconJun 4, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC-T) presents a mixed outlook among experts, with many pointing to its strong capital position, healthy growth in Asia, and attractive dividend yield as positives. Some analysts highlight a recent dip due to earnings concerns, yet the overall sentiment leans toward the belief that MFC is fundamentally sound, especially with its strategic initiatives in wealth management and the Asian market. However, there is caution about potential market volatility and the necessity for macroeconomic factors to shift positively for the stock to reach new heights. The company is seen as a reliable income stock rather than a growth play, with its valuation being reasonable in comparison to peers, although many believe it may be undervalued relative to its long-term potential.

consensus icon
Consensus
Hold
valuation icon
Valuation
Fair Value
review icon
Similar
GWO
HOLD

He has owned it for a long time and is overweight for clients. He is not buying more at these levels but also not selling. It is still reasonably valued and pays a 4 1/2% dividend.

HOLD

Higher rates are actually good for insurance companies.

PAST TOP PICK
(A Top Pick Jun 28/23, Up 42%)

Excellent business that has seen very strong share performance. Will continue to own shares. Great balance sheet with stable dividend. Continues to reinvest in business. Also getting exposure to USA and Asia business lines as well. 

PARTIAL BUY

Lifeco's have been out performing Canadian banks lately. Has owned shares for a long time. Strong share price lately nice to see. Solid dividend yield good for investors. Would recommend a partial position. 

TOP PICK

Cheaper PE at 8.5x than peers, decent growth rate of 9%. Nice beat recently with Asia up 21%, EPS up 18%, ROE starting to get higher at 16.7%. Helped by rates being higher for longer. Insurance companies still better than the banks, and fund flows continue. Nice yield of 4.5%, with 8% growth.

Ideally, he'd like to buy lower. But can still buy here and it will work for your portfolio over the next 1-2 years.

(Analysts’ price target is $37.37)
HOLD

Stock popped after got lower-return LTC off its books. Cleaning up commercial real estate used to back the LTC liabilities. If this progress continues, a strong hold.

HOLD

Company has been range bound for ~10-15 years. Recent strength in stock price good for investors. Higher interest rates good for investors. If interest rates fall, not good for business. Would recommend holding shares. 

Unspecified

Patience pays off but the better move has already been made. It is a slow growth company. It has some struggles with its Asian operations but has a decent dividend yield (well covered), not too expensive and is safe.

HOLD

Debating quality of company within investment team. Sees money coming out of financial sector in Canada - going into insurance companies. Not overly positive on direction of business. If expectations for rate cuts continues - will be good for business. Would recommend investors to hold the position. 

BUY

Transformed itself, market's recognizing that. Can confidently buy now. Pretty competitive, safe dividend yield, around 5%. Taken steps to pivot business away from riskier liabilities. Still trades at a discount.

PAST TOP PICK
(A Top Pick Mar 31/23, Up 41%)

The moving averages are trending higher and up a new leg higher. Has great exposure to a fast-growing Asian market. Pays a 4.9% dividend and cheap at 1.5x price-to-book.

TOP PICK

Their big product was guaranteeing a life insurance policy on stock returns. So, when the market melted down, there was a big scare. Now, the market has come back, and those policies won't lose as much. MFC used to be held up by a fortress balance sheet. 15 years later, they've grown into that balance sheet. Saw nice earnings growth in 2023 and expects it also for 2024.

(Analysts’ price target is $35.37)
PAST TOP PICK
(A Top Pick Dec 12/22, Up 44%)

Business headed in right direction. Profitability increasing, return on equity also strong. New management has turned things around. Current yield ~5% is very stable. Interest rates not a concern - have weather rising rates well. Would continue to buy - still owns shares. 

BUY

MFC is the name in the Insurance space that keeps working. A few years ago, it was like that cough syrup -- doesn't taste good, but it works. Insurance companies are set to outperform banks. MFC is #1, SLF #2, POW #3.

TOP PICK

Share price up nicely - a little strong, but overall very good trends.. Excellent balance sheet strength. Capital allocation very strong the past few years. Excellent CEO. Recently selling problematic assets. Seeing rebound in Asia market. Good for shareholders in the long term. Core holding in income portfolio. 

Showing 76 to 90 of 2,279 entries